Oramed Pharmaceuticals
ORMP
$2.30
Share price
-1.29%
Change (1 day)
-36.64%
Change (1 year)
Categories
Oramed Pharmaceuticals (ORMP) - P/B ratio
P/B ratio as of May 2024 : 0.5812
According to Oramed Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.5812.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Oramed Pharmaceuticals - P/B ratio (from 2008 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.5721 | -81.62% |
| 2022-12-31 | 3.11 | -2.49% |
| 2021-12-31 | 3.19 | -10.79% |
| 2020-12-31 | 3.58 | -31.48% |
| 2019-12-31 | 5.22 | 189.06% |
| 2018-12-31 | 1.81 | -68.1% |
| 2017-12-31 | 5.66 | 67.26% |
| 2016-12-31 | 3.39 | -23.08% |
| 2015-12-31 | 4.40 | 111.52% |
| 2014-12-31 | 2.08 | -87.61% |
| 2013-12-31 | 16.8 | 267.54% |
| 2012-12-31 | 4.57 | -22.81% |
| 2011-12-31 | 5.92 | -72.67% |
| 2010-12-31 | 21.7 | 102.66% |
| 2009-12-31 | 10.7 | 77.63% |
| 2008-12-31 | 6.02 | |
| 2007-12-31 | N/A | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | 41.4 | 7,024.87% | 🇩🇰 Denmark |
 Sanofi SNY | 1.50 | 157.85% | 🇫🇷 France |
 Ultragenyx RARE | 12.9 | 2,113.16% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | 7.14 | 1,129.23% | 🇺🇸 USA |
 Compugen CGEN | 2.92 | 402.88% | 🇮🇱 Israel |